Status:
COMPLETED
Variance of Oral Methadone Dosage: Description of Implicated Factors
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Heroin Dependence
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to describe clinical, pharmacokinetic and genetic factors associated with the variance of oral methadone dosage for patients at the steady state of heroin dependence maint...
Detailed Description
Patients at the steady state of methadone maintenance treatment may receive oral dosage ranging from 5 to 130 mg per day in our clinical practice. This study is aimed at providing a comprehensive cros...
Eligibility Criteria
Inclusion
- heroin dependence
- under maintenance treatment with methadone
- at steady state: stable oral methadone dosage since 3 months at least
Exclusion
- current heroin dependence or abuse
- current cocaine and/or alcohol and/or sedatives dependence
- pregnancy
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT00894452
Start Date
December 1 2008
End Date
May 1 2013
Last Update
September 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
hospital Lariboisière-Fernand-WidalCity: PARIS
Paris, France, 75010